Warning Confirms Some Supplement GMP Violations Remain Common In US
Executive Summary
An Oregon factory’s citations received by the FDA are among the most common violations the agency finds during inspections, ORA Office of Human and Animal Food Operations deputy director said.
You may also be interested in...
Qualifying Suppliers For US Supplement Ingredient Identity Requirement Still An Option With Thorns
Failing to qualify suppliers “one of the more common citations” FDA inspectors find at supplement facilities, says ORA deputy director Michael Dutcher. “If you're not sort of reconfirming once in a while it could lead to a problem with your products that you weren't even expecting.”
Remote Assessments A Welcome Option For US FDA, But They’re Not Every Firm’s First Choice
“We're looking to expand the use of this tool make it a more routine part of our operations going forward,” says Michael Dutcher, deputy director, ORA Office of Human and Animal Food Operations. “In general, the response from industry has been pretty positive” about RRAs.
US FDA Testing ‘Discount’ Multivitamins 'Very Soon’
“Over the last year or so, we've had some concerns about the quality of some of the discount multivitamins that are on the market,” says Michael Dutcher, director of the ORA Office of Human and Animal Food Operations' Minneapolis region.